Evidence map›Paper›PMID 40458180›Full record

ArticleFrontiers in endocrinology2025

Association between triglyceride-glucose index and the risk of cardiometabolic diseases in metabolically healthy obese individuals: a prospective cohort study.

Yanjuan Chen, Weiqiang Wu, Zefeng Cai, Kuangyi Wu, Huancong Zheng, Peng Fu, Yuxian Wang, Xianxuan Wang, Yulong Lan, Shuohua Chen and 2 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yanjuan Chen *Department of Endocrinology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Weiqiang Wu *Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Zefeng Cai *Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Kuangyi WuDepartment of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Huancong ZhengDepartment of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Peng FuDepartment of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yuxian WangDepartment of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xianxuan WangDepartment of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Yulong LanDepartment of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Shuohua ChenDepartment of Cardiology, Kailuan General Hospital, Tangshan, China.
Shouling WuDepartment of Cardiology, Kailuan General Hospital, Tangshan, China.
Youren ChenDepartment of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metabolically healthy obese (MHO) individuals meet the criteria for obesity with normal blood glucose and lipid metabolism parameters, absence of hypertension, and no concurrent cardiovascular diseases. However, the association between the triglyceride-glucose (TyG) index and the risk of cardiometabolic disease (CMD) in MHO individuals remains unclear. Methods and results: This study included obese individuals who underwent health examinations at Kailuan Group from 2006 to 2010, whom without a history of hypertension, diabetes, hyperlipidemia, cardiovascular disease, as the study participants. A total of 4750 participants were included in this study. The TyG index was calculated as ln[TG (mg/dL) × FPG (mg/dL)/2] and divided into four groups based on quartiles: Q1 group (<8.18); Q2 group (8.18-8.41); Q3 group (8.42-8.62); Q4 group (≥8.63). The Cox proportional hazards model was used to assess the relationship between the TyG index and risk of CMD incidence. During a median follow-up period of 11 (IQR 10.3, 11.2) years, 826 participants experienced CMD, among whom 131 participants developed coronary heart disease, 215 participants developed stroke, and 542 participants developed diabetes. After adjusting for multiple confounding factors, compared with the Q1 group, the adjusted HRs (95% CI) for CMD in the Q2-Q4 groups were 1.33 (1.03, 1.65), 1.37 (1.04, 1.82), and 2.04 (1.56, 2.68) ( Conclusions: A high TyG index increases the risk of CMD in MHO individuals. Monitoring and maintaining an appropriate TyG index may contribute to the prevention of CMD risk in MHO individuals.

Indexed as

Blood GlucoseCardiovascular DiseasesObesity, Metabolically BenignTriglyceridesAdultCardiometabolic Risk FactorsFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRisk FactorsBlood GlucoseTriglyceridescardiometabolic diseasecoronary heart diseasediabetesmetabolically healthy obesestroketriglyceride-glucose index

Identifiers

PMID40458180
PMCPMC12127177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.